Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments

AI Briefing

• – Compass Pathways collaborates with Osmind to advance independent clinic readiness for psychedelic treatments.
• – The collaboration aims to inform how small-to-medium sized clinics can deliver novel psychedelic treatments if FDA approved.
• – The partnership will support the integration of psychedelic therapies into clinical practice nationwide.